Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vbi Vaccines Inc CS (NQ: VBIV )

0.0653 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0653
Bid (Size) 0.0450 (157)
Ask (Size) 0.0488 (112)
Prev. Close 0.0653
Today's Range 0.0653 - 0.0653
52wk Range 0.0553 - 1.350
Shares Outstanding 28,682,275
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
Via InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-89.40%
-89.40%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-89.30%
-89.30%
1 Year
-89.37%
-89.37%

More News

Read More
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is VBI Vaccines (VBIV) Stock Up 62% Today?
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Tumbles 950 Points; ISM Services PMI Surges In July
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
Via Benzinga
VBI Vaccines Provides an Update on its Restructuring Proceedings
From VBI Vaccines Inc.
Via Business Wire
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Results of Annual General Meeting
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
From VBI Vaccines Inc.
Via Business Wire
VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
VBI Vaccines Reports First Quarter 2024 Financial Results
From VBI Vaccines Inc.
Via Business Wire
VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
VBI Vaccines Reports Full Year 2023 Financial Results
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From VBI Vaccines Inc.
Via Business Wire
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From VBI Vaccines Inc.
Via Business Wire
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
From VBI Vaccines Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.